Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Change in Inventory (2016 - 2017)

Lisata Therapeutics (LSTA) has disclosed Change in Inventory for 8 consecutive years, with -$43657.0 as the latest value for Q1 2017.

  • For the quarter ending Q1 2017, Change in Inventory fell 104.06% year-over-year to -$43657.0, compared with a TTM value of -$447537.0 through Mar 2017, down 222.67%, and an annual FY2016 reading of $670555.0, up 94.5% over the prior year.
  • Change in Inventory was -$43657.0 for Q1 2017 at Lisata Therapeutics, up from -$733679.0 in the prior quarter.
  • Across five years, Change in Inventory topped out at $1.2 million in Q2 2016 and bottomed at -$1.5 million in Q2 2013.
  • Average Change in Inventory over 5 years is $142683.2, with a median of $375131.0 recorded in 2015.
  • The sharpest move saw Change in Inventory tumbled 594.6% in 2013, then soared 412.85% in 2015.
  • Year by year, Change in Inventory stood at $740857.0 in 2013, then tumbled by 42.68% to $424687.0 in 2014, then crashed by 202.87% to -$436876.0 in 2015, then plummeted by 67.94% to -$733679.0 in 2016, then skyrocketed by 94.05% to -$43657.0 in 2017.
  • Business Quant data shows Change in Inventory for LSTA at -$43657.0 in Q1 2017, -$733679.0 in Q4 2016, and -$833800.0 in Q3 2016.